跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL
Approved
STANDARD
RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL
Glenmark Pharmaceuticals S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 30, 2021
Approval ID
089225bea78aa610
Company
Glenmark Pharmaceuticals S.R.O.
Type
Standard
Approval Details
Approval Id
089225bea78aa610
Drug Cima Aemps Name
RYALTRIS 25 MICROGRAMOS/600 MICROGRAMOS/PULSACION SUSPENSION PARA PULVERIZACION NASAL
Register Number
86059
Holder Company Name
Glenmark Pharmaceuticals S.R.O.
Marketing Company Name
Laboratorios Menarini S.A.
Holder Company Detail Path
/organization/glenmark-pharmaceuticals-s-r-o
Authorization Date
2021-06-30
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
25 microgramos/600 microgramos/dosis
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Glenmark Pharmaceuticals S.R.O.
Company Detail Path
/organization/glenmark-pharmaceuticals-s-r-o
Company Information
Pharmaceutical Company Name
Glenmark Pharmaceuticals s.r.o.
Country Name
Czech Republic
City Name
praha,hlavní město praha,country_cz
Address
Hvězdova 1716/2B
Active Ingredients
OLOPATADINA HIDROCLORURO
665 µg
MOMETASONA FUROATO MONOHIDRATO
25,86 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 30, 2021
Approval ID
089225bea78aa610
Type
Standard
Back to CIMA-AEMPS Approvals